AtCor Medical Holdings Ltd. provided earnings guidance for the second half of 2013. The company warned it would report revenue below company expectations in the first half due to delays in finalising pharmaceutical contracts that were expected to be signed during the second quarter. As a result, the company will report sales in the range of $2.6 million to $2.7 million, around 50% lower than sales reported in first half of 2013.

The company expects to report a loss in the region of $1 million. The company also expects to report positive cash flows of $1.1 million for the half and cash of $4.1 million at December 31, 2013 and anticipates positive cash flow for the full year.